← Evidence map

TrialThe oncologist2021

Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer.

John H Strickler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2021
2022
2023
2024
2025
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 33469991